HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo

Neli Kachamakova‐Trojanowska; Paulina Podkalicka; Tomasz Bogacz; Szymon A. Barwacz; Alicja Józkowicz; Jozef Dulak; Agnieszka Łoboda

doi:10.1016/j.bcp.2020.113922

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro

Zhu Zhu, Liao Cui, Jing Yang, Chi Teng Vong, Hu Y, Jianbo Xiao, Ging Chan, Zhiwei He, Zhangfeng Zhong

Article2015

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

Huimin Zhang, Haiquan Lu, Lisha Xiang, John W. Bullen, Chuanzhao Zhang, Debangshu Samanta, Daniele M. Gilkes, Jianjun He, Gregg L. Friedman

Article2018

In Vitro Assays of Breast Cancer Stem Cells

Debangshu Samanta, Gregg L. Friedman

Article2021

HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells

Haiquan Lu, Yajing Lyu, Thi My Linh Tran, Jie Lan, Yangyiran Xie, Yongkang Yang, Naveena L. Murugan, Yueyang J. Wang, Gregg L. Friedman

Article2009

Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects <i>in vitro</i> and <i>in vivo</i>

Sylvianna Georgaki, Margarita Skopeliti, Marinos Tsiatas, Katerina Nicolaou, Kyriaki Ioannou, Alan J. Husband, Aristotelis Bamias, Meletios A Dimopoulos, Andreas I. Constantinou, Ourania Tsitsilonis